Cocoa-rich Bioflavanol Supplementation Effects During Cold Exposure

NCT ID: NCT04359082

Last Updated: 2021-04-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-13

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose is to test whether cocoa-rich bioflavanols can improve blood flow to the hand and fingers and improve hand function/dexterity during cold exposure. Secondary purpose is to understand whether bioflavanol supplementation can change the gut microbiome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Loss of manual dexterity significantly impacts Warfighter effectiveness and lethality on the cold-weather battlefield. Identifying countermeasures that improve hand and finger temperatures, hand and finger blood flow, manual dexterity, and thermal comfort may lead to better Warfighter performance. A primary purpose of this study is to test the efficacy of a commercial off-the-shelf cocoa-rich bioflavanol product on hand/finger blood flow and temperature, manual dexterity, and thermal comfort during whole-body cold exposure. Another primary purpose is to determine the effect of bioflavanols on the finger cold-induced vasodilation (CIVD) response to cold-water immersion. Secondary purposes are to determine if: a) cocoa-rich flavanols stimulate the growth of beneficial gut bacteria and b) impact attention and effort perception during dexterity task completion in the cold. Two experimental studies (n = 20 in each study, 10 women and 10 men, 18-49 yr) will be conducted. Experiment #1 consists of immersing the middle finger in cold water (4°C) for 30 minutes; experiment #2 consists of whole-body cold exposure (8°C air, 90-min exposure, wearing cold-weather clothing but bare-handed). In both experiments, outcomes will be measured after both acute flavanol or placebo ingestion and chronic ingestion of flavanol/placebo (8 days of supplementation). Daily flavanol ingestion will be 900 mg/day. Volunteers will serve as their own controls in this crossover, double-blind research design. The washout period between flavanol and placebo treatments will be at least 2 weeks (longer for women who will be tested only during the follicular phase). Measurements during these tests include skin temperature, skin blood flow, fine and gross motor dexterity, thermal comfort, and effort perception. Fecal samples, in both experiments, will be collected before and after 8 days of cocoa-rich bioflavanol supplementation to examine if bioflavanol supplementation increases the number of beneficial bacteria in the gut microbiome. Information from this study will inform combat nutrition developers about the efficacy of cocoa-rich bioflavanols and possible inclusion into cold-weather field rations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cold Exposure Manual Dexterity Gut Microbiome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Randomized, double-blind, cross-over controlled trial
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators
Double-blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Placebo for 8 straight days

Group Type PLACEBO_COMPARATOR

Placebo Pill

Intervention Type OTHER

Placebo pill has no bioflavanols with 30 mg theobromine and 10 mg caffeine

Bioflavanol

Bioflavanol supplementation for 8 days at 900 mg flavanol per day

Group Type EXPERIMENTAL

CocoaVia supplement

Intervention Type DIETARY_SUPPLEMENT

CocoaVia is a dietary supplement that has concentrated bioflavanols of 225 mg flavanols per pill along with 30 mg theobromine and 10 mg caffeine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CocoaVia supplement

CocoaVia is a dietary supplement that has concentrated bioflavanols of 225 mg flavanols per pill along with 30 mg theobromine and 10 mg caffeine

Intervention Type DIETARY_SUPPLEMENT

Placebo Pill

Placebo pill has no bioflavanols with 30 mg theobromine and 10 mg caffeine

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age - 18-49 years (17-49 for active military).
* Refrain from the following for 2 weeks before and during the study (including the washout period): consumption of flavanol rich foods including cocoa, chocolate, apples, red, white, and sweet wine, apricots, blueberries, peaches/nectarines, plums, grapes, strawberries, pecans (no more than ½ cup/day, pistachios, (no more than ½ cup per day), and apple juice.
* Participants not to change their daily intakes of tea (green or black) or coffee.

Exclusion Criteria

* History of cold injuries.
* Raynaud's syndrome.
* Cold-induced asthma/bronchospasm
* Difficulty swallowing pills.
* Previous hand/finger injuries that impair dexterity and hand function.
* Metal hardware (plates/screws) in the forearms and hands.
* Blood donation in last 8 weeks.
* Medicine use (including any over the counter medication such as Tylenol, Advil, Sudafed, etc…), with the exception of birth control and a multi-vitamin.
* Known allergies to medical adhesives or cocoa/chocolate.
* History of disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis; or previous gastrointestinal surgery.
* No planned MRI during the study or within 2 days after completing a cold test.
* Use of dietary supplements (to include probiotics and prebiotics), with exception of multi-vitamin containing up to 100% of the recommended daily allowance (RDA).
* No exercise or smoking within 8 hours of testing.
* Pregnant or breastfeeding.
* Oral antibiotic use within 3 months of study participation.
* Inability or unwillingness to not consume fermented food products or prebiotic-containing food products for 2 weeks prior to and throughout study participation. Examples include kefir, kombucha, aged cheese, pickles, sauerkraut, sour cream, tempeh, yogurt, kimchi, miso, vinegar, sourdough bread, wine and beer.
* Colonoscopy within 3 months of study participation.
* On average has a bowel movement less frequently than every other day.
Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

United States Army Research Institute of Environmental Medicine

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John W Castellani, PhD

Role: PRINCIPAL_INVESTIGATOR

US Army Research Institute of Environmental Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

John W Castellani

Natick, Massachusetts, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

John W Castellani, PhD

Role: CONTACT

508-206-2195

Billie Alba, PhD

Role: CONTACT

508-206-2171

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

John W Castellani, PhD

Role: primary

508-206-2195

References

Explore related publications, articles, or registry entries linked to this study.

Alba BK, Greenfield AM, Yurkevicius BR, Jones ML, Castellani JW. Short-term cocoa bioflavanol supplementation does not improve cold-induced vasodilation in young healthy adults. Eur J Appl Physiol. 2024 May;124(5):1523-1534. doi: 10.1007/s00421-023-05380-4. Epub 2023 Dec 27.

Reference Type DERIVED
PMID: 38150009 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form: CIVD

View Document

Document Type: Informed Consent Form: Cold Air

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18-27-H

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Antioxidant Treatment of Type 2 Diabetes
NCT00609102 COMPLETED EARLY_PHASE1
Healthy Aging Through Functional Food
NCT02095873 COMPLETED PHASE1/PHASE2